AGN-201904

DB13135InvestigationalSmall molecule

Agn 201904 has been used in trials studying the prevention of Peptic Ulcer.

Mechanism: Pharmacologically active on Potassium-transporting ATPase alpha chain 1 and Hydrogen potassium ATPase
Curator reviewed
Formula / weight: C₂₅H₂₅N₃O₈S₂ · 559.61 g/mol (avg)
Code names: AGN-201904

Resolves to

Compound

Structure

InChIKeyPPCGSVWOZKNPCX-UHFFFAOYSA-NSMILESCOC1=CC2=C(C=C1)N(C(=N2)S(=O)CC1=NC=C(C)C(OC)=C1C)S(=O)(=O)C1=CC=C(OCC(O)=O)C=C1

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Drug interactionStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with AGN-201904, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.